glp 1 patient education Ontario's Anesthesiologists | ICYMI: Recently, we published a concise, patient-friendly article that looks at what people taking GLP-1 medications need to know about GLP-1 Medications: What You Need

Summary Retatrutide, a triple agonist now in phase 3 trials, has the potential to become the most effective pharmacological treatment for obesity while also offering substantial benefits in T2D management and other cardiometabolic risk factors

Continued research showing the benefits of maintenance therapy may help reduce barriers to care, particularly when it comes to insurance coverage and long-term treatment planning. Mir Ali, MD

For 503A state-licensed pharmacies - the pathway most telehealth platforms use for patient-specific prescriptions - a narrower legal framework applies

The FDA has documented significant risks associated with unverified medication sources

Afzaal M, Saeed F, Shah YA, et al